Skip to main content
Premium Trial:

Request an Annual Quote

454 Pays Celoxica $1.5M to Use Its Software In Neandertal Genome Project

NEW YORK (GenomeWeb News) – 454 Life Sciences has used software made by Celoxica Holdings to help it in its project to sequence the Neandertal genome, according to a British online news service.
Life Style Extra cited a Celoxica statement saying that 454 has “invested” $1.5 million in the company’s products, which it uses “to help accelerate the computing performance” of its sequencing technology.

According to LSE, the Celoxica RC2000 board provides the FPGA co-processing engine for the 454 sequencer, and that 454 uses Celoxica's DK Design Suite to program the algorithms in the FPGA.

Officials from 454 were not immediately available to confirm the report.
According to Celoxica's website, the company provides C-based design and behavioral synthesis tools. It provides electronic system level (ESL) co-design products that incorporate ANSI-C, Handel-C, and SystemC languages.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.